GLOBALIZATION

American FDA New Drug Declaration and Clinical Research Advantages

The United States reported working with clinical research institutions and has successfully introduced more than 10 varieties of 6 Chinese companies to Phase III clinical experience(including green leaf pharmaceuticals).

Scale R&D

A world-class R&D partnership

A Sino-U.S. cooperative R&D platform collaborated with Johns Hopkins University to develop NS new drugs and successfully screened MT1006 and MT2006 series of compounds. It is expected that human research will be carried out in 2018.

cooperate

Research and development facilities and global drug development integration capabilities

3500 ping trial scale industrialization base, 1 1Kg or more polypeptide raw material production line, 1 polypeptide purification pilot line, 1 freeze-dried preparation production line, 1 microsphere sustained release pilot production line.